Grail (GRAL) Profit After Tax (2023 - 2026)
Grail's (GRAL) quarterly Profit After Tax came in at -$110.2 million in Q2 2026, up 3.28% on a YoY basis from -$106.7 million in Q2 2025, and down 18.31% quarter-over-quarter from -$93.2 million in Q1 2026.
Analysis
Grail (GRAL) Profit After Tax (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Profit After Tax for 4 consecutive years, with -$110.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax rose 3.28% year-over-year to -$110.2 million; the trailing twelve-month figure through Jun 2026 stood at -$391.6 million (up 11.6% YoY), and the FY2025 full-year result was -$408.4 million, up 79.85% from the prior year.
- Profit After Tax eased to -$110.2 million in Q2 2026 per GRAL's latest filing, from -$93.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$89.0 million in Q3 2025 and bottomed at -$1.6 billion in Q2 2024.
- Historically, Profit After Tax has averaged -$300.8 million across 4 years, with a median of -$114.0 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax plunged 721.23% in 2024, then surged 92.81% in 2025.
- Over 4 years, Profit After Tax stood at -$187.5 million in 2023, then surged by 48.24% to -$97.1 million in 2024, then retreated by 2.17% to -$99.2 million in 2025, then decreased by 11.16% to -$110.2 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$110.2 million, -$93.2 million, and -$99.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -66.97 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 334.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 5.64 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -1.00 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -39.94 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -110.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -110.25 Mn |
| Mar 31, 2026 | -93.19 Mn |
| Dec 31, 2025 | -99.18 Mn |
| Sep 30, 2025 | -88.98 Mn |
| Jun 30, 2025 | -113.99 Mn |
| Mar 31, 2025 | -106.21 Mn |
| Dec 31, 2024 | -97.07 Mn |
| Sep 30, 2024 | -125.69 Mn |
| Jun 30, 2024 | -1.59 Bn |
| Mar 31, 2024 | -218.91 Mn |
| Dec 31, 2023 | -187.53 Mn |
| Oct 1, 2023 | -891.45 Mn |
| Jun 30, 2023 | -193.04 Mn |